BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11302124)

  • 21. Plasmablastic lymphoma presenting as a gingival growth in a previously undiagnosed HIV-positive patient: a case report.
    Desai RS; Vanaki SS; Puranik RS; Giraddi G; Pujari RV
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1358-61. PubMed ID: 17577502
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas.
    Ford R; Tamayo A; Martin B; Niu K; Claypool K; Cabanillas F; Ambrus J
    Blood; 1995 Jul; 86(1):283-93. PubMed ID: 7795235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
    Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
    Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic non-Hodgkin B-cell lymphoma encountered as a vanishing choroidal mass.
    Apte RS; Al-Abdulla NA; Green WR; Schachat AP; DeJong MR; DiBernardo C; Handa JT
    Arch Ophthalmol; 2005 Jan; 123(1):105-9. PubMed ID: 15642822
    [No Abstract]   [Full Text] [Related]  

  • 25. Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas.
    Pagnano KB; Silva MD; Vassallo J; Aranha FJ; Saad ST
    Acta Haematol; 2002; 107(1):29-34. PubMed ID: 11818669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous regression of malignant lymphoma of the breast.
    Iihara K; Yamaguchi K; Nishimura Y; Iwasaki T; Suzuki K; Hirabayashi Y
    Pathol Int; 2004 Jul; 54(7):537-42. PubMed ID: 15189510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary hepatic lymphoma with spindle cell components: a case report.
    Hayashi H; Ohtani H; Ueda T; Yamaguchi J; Izawa K; Hayashida T; Higami Y; Shimokawa I
    Virchows Arch; 2006 Nov; 449(5):591-6. PubMed ID: 16988839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New entities and new tools in hematopathology as proposed by the 2016 WHO classification: Case 7].
    Laurent C; Brousset P
    Ann Pathol; 2019 Sep; 39(5):335-338. PubMed ID: 31405614
    [No Abstract]   [Full Text] [Related]  

  • 32. CD30 expression is common in mediastinal large B-cell lymphoma.
    Higgins JP; Warnke RA
    Am J Clin Pathol; 1999 Aug; 112(2):241-7. PubMed ID: 10439805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large B-cell lymphoma of thyroid. Two cases with a marginal zone distribution of the neoplastic cells.
    Higgins JP; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):264-70. PubMed ID: 10941342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
    Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
    Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
    Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
    Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features of primary intestinal lymphoma in Taiwan: a study of 21 resected cases.
    Chuang SS; Li CY
    Pathol Res Pract; 2002; 198(6):381-8. PubMed ID: 12166894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features.
    Wang J; Sun NC; Nozawa Y; Arber DA; Chu P; Chang KL; Weiss LM
    Histopathology; 2001 Nov; 39(5):476-81. PubMed ID: 11737305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous Regression of Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
    Toberer F; Mechtersheimer G; Jaschinski H; Enk A; Hakim-Meibodi L; Haenssle HA
    Acta Derm Venereol; 2018 Jun; 98(6):608-609. PubMed ID: 29508000
    [No Abstract]   [Full Text] [Related]  

  • 39. Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma.
    Nava VE; Cohen P; Bishop M; Fowler D; Jaffe ES; Ozdemirli M
    Am J Surg Pathol; 2007 Mar; 31(3):476-80. PubMed ID: 17325491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma.
    Rantanen S; Monni O; Joensuu H; Franssila K; Knuutila S
    Leuk Lymphoma; 2001; 42(5):1089-98. PubMed ID: 11697626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.